Aza-A-ring indenoisoquinoline topoisomerase I poisons
US10759795B2 · kind B2 · utility
0Cited by
21References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2017 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Mar 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein pertains to four series of aza-A-ring indenoisoquinolines, which are inhibitors of topoisomerase IB (Top1), and the processes for preparing said aza-A-ring indenoisoquinolines. Also described are methods for treating cancer in mammals using the described aza-A-ring indenoisoquinoline compounds or pharmaceutical formulations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.